- ►chestpubs.org MN Levine, G Raskob, RJ Beyth, C Kearon, … - Chest, 2004 - chestjournal.chestpubs.org This chapter about hemorrhagic complications of anticoagulant treatment is part
of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Bleeding is the major complication of ... Cited by 1078 - Related articles - BL Direct - All 14 versions
C Kearon, SR Kahn, G Agnelli, S Goldhaber, … - Chest, 2008 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.08-0658 2008;133;454S-545S Chest Gary E. Raskob and
Anthony J. Comerota Clive Kearon, Susan R. Kahn, Giancarlo ... Cited by 211 - Related articles - All 16 versions
- ►ahajournals.org RG Hart, SB Tonarelli, LA Pearce - Stroke, 2005 - Am Heart Assoc Summary of Review— ICH rates range from 0.3% to 0.6% per year during oral
anticoagulation in recent reports. Major risk factors are advanced patient age,
elevated blood pressure, intensity of anticoagulation, and previous ... Cited by 108 - Related articles - All 9 versions
M Wadelius, M Pirmohamed - The Pharmacogenomics Journal, 2006 - nature.com Warfarin is an anticoagulant that is difficult to use because of the wide
variation in dose required to achieve a therapeutic effect, and the risk of
serious bleeding. Warfarin acts by interfering with the recycling of ... Cited by 90 - Related articles - BL Direct - All 4 versions
- ►ahajournals.org C Kearon - Circulation, 2004 - Am Heart Assoc Long-term treatment of venous thromboembolism (VTE) focuses mainly on the
duration of anticoagulant therapy, usually with vitamin K (VK) antagonists. The
duration of therapy should be individualized based on the risk of recurrent ... Cited by 77 - Related articles - BL Direct - All 8 versions
- ►vhpharmsci.com [PDF] PS Wells, DR Anderson, MA Rodger, MA Forgie … - Archives of internal medicine, 2005 - Am Med Assoc Methods We compared 2 LMWH products, tinzaparin and dalteparin sodium, for the
treatment of acute DVT and PE in a randomized, controlled clinical trial of
consecutive outpatients presenting to a venous thromboembolism service at 4 ... Cited by 65 - Related articles - All 11 versions
- ►chestjournal.org [PDF] C van Walraven, A Jennings, N Oake, D … - Chest, 2006 - chestjournal.chestpubs.org Page 1. DOI 10.1378/chest.129.5.1155 2006;129;1155-1166 Chest Alan J. Forster Carl
van Walraven, Alison Jennings, Natalie Oake, Dean Fergusson and ... Cited by 64 - Related articles - All 7 versions
CL Hann, MB Streiff - Blood reviews, 2005 - Elsevier Venous thromboembolism (VTE) is a significant cause of morbidity and mortality
worldwide. Anticoagulation is the preferred treatment for VTE, however, in
selected patient populations, the risk of bleeding from anticoagulation ... Cited by 62 - Related articles - All 13 versions
JD Douketis, PB Berger, AS Dunn, AK Jaffer, … - Chest, 2008 - chestjournal.chestpubs.org This article discusses the perioperative management of antithrombotic therapy
and is part of the American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines (8th Edition). The primary objectives of this article ... Cited by 64 - Related articles - BL Direct - All 16 versions
S Schulman, RJ Beyth, C Kearon, MN Levine - Chest, 2008 - chestjournal.chestpubs.org This article about hemorrhagic complications of anticoagulant and thrombolytic
treatment is part of the Antithrombotic and Thrombolytic Therapy: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines ... Cited by 60 - Related articles - All 12 versions
